Impact of different age ranges on the benefits and harms of the breast cancer screening programme by the EU-TOPIA tool.
Marina Pinto-CarbóMercedes Vanaclocha-EspíJavier Martín-PozueloPaula Romeo-CerveraMarta Hernández-GarcíaJosefa IbáñezSusana Castán-CameoDolores SalasNicolien T van RavesteynHarry de KoningOscar ZurriagaAna Molina-BarcelóPublished in: European journal of public health (2024)
As the age range increases, so does not only the reduction in BC mortality, but also the probability of FP and overdiagnosis.